Glaukos (STU:6GJ) Stock Based Compensation : €41.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Glaukos Stock Based Compensation?

Glaukos's Stock Based Compensation for the three months ended in Mar. 2024 was €10.3 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was €41.1 Mil.

Glaukos Stock Based Compensation Historical Data

The historical data trend for Glaukos's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Stock Based Compensation Chart

Glaukos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

32.75

38.21

26.68

36.40

39.92

Glaukos Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Stock Based Compensation	Get a 7-Day Free Trial															9.51	9.11	9.82	11.91	10.28

Glaukos Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €41.1 Mil.

Glaukos Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Glaukos's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Glaukos (STU:6GJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (STU:6GJ) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

GKOS:USA

Address

One Glaukos Way, Aliso Viejo, CA, USA, 92656

Website

https://www.glaukos.com

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (STU:6GJ) Headlines

No Headlines